The study's senior author Robert S. DiPaola, MD, who is the director of Rutgers Cancer Institute of New Jersey and helped lead the design of the protocol a decade ago when he was the national chairman of the ECOG
Genitourinary Committee, says the findings are significant.
Not exact matches
He has served on National Cancer Institute (NCI) Steering
Committees for
Genitourinary Cancer (GUSC) and Investigational Drugs (IDSC)- Immunotherapy Task Force, and is a senior editor for Cancer Immunology Research.
Michael Carducci, MD, AEGON Professor of Prostate Cancer Research and professor of oncology at Johns Hopkins Kimmel Cancer Center, who is also chair of the Prostate Cancer Subcommittee within the
Genitourinary Oncology
Committee of ECOG - ACRIN agrees.